Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01892423 · ClinicalTrials.gov registry record · NA
Repeat Insult Patch Test for Daily Advance Cetaphil Moisturizing Lotion
A NA study, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 146
- Enrollment target
NCT01892423 is a NA study that has completed, run by Galderma R&D. The registered enrollment target is 146 participants.
The verdict
NCT01892423, a NA study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 146 participants
- Enrollment target
Study Summary
Human repeat insult patch test to assess the potential for Cetaphil Moisturizing Lotion Daily Advance to induce sensitization to the skin
Interventions
- OTHER Cetaphil Moisturizing Lotion Daily Advance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2006-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01892423
The ClinicalTrials.gov registry entry for NCT01892423 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cetaphil Moisturizing Lotion Daily Advance is the first listed.
NCT01892423 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01892423 about?
NCT01892423 is a clinical study titled "Repeat Insult Patch Test for Daily Advance Cetaphil Moisturizing Lotion". Human repeat insult patch test to assess the potential for Cetaphil Moisturizing Lotion Daily Advance to induce sensitization to the skin
What is the current status of trial NCT01892423?
This trial is currently completed. It is a NA study. The enrollment target is 146 participants. The study started on 2006-08.
What interventions are being tested in trial NCT01892423?
The interventions under investigation include: Cetaphil Moisturizing Lotion Daily Advance (OTHER).
Who is sponsoring clinical trial NCT01892423?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.